LeonaBio, Inc. LONA
3.25
(1.74)
(34.87%)
as of 25 Sep
- Market cap
- $54.3M
- P/E
- 0.0×
Follow LONA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
9.70 | 1.88 | 10.38 | 7.01 |
Net Debt/EBITDA |
3.76 | 1.13 | 3.93 | 2.63 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.71 | 0.23 | 0.63 | 0.89 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.18) | (4.54) | (1.10) | (0.71) | |
Cash per Share |
6.40 | 20.66 | 3.56 | 2.15 | |
Shareholders Equity per Share |
6.79 | 6.50 | 2.59 | 1.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.79 | 6.50 | 2.59 | 1.42 | |
Free Cash Flow |
(4.67) | (19.40) | (20.90) | (16.96) | |
Working Capital |
24.24 | 41.96 | 62.54 | 46.99 | |
Net Current Asset Value |
23.78 | 25.10 | 46.92 | 31.51 | |
| Other line items | |||||
Quick Ratio |
9.05 | 1.86 | 10.15 | 6.53 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.18) | (4.54) | (1.10) | (0.71) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
0.33 | 2.45 | 1.32 | 1.30 | |
Average Assets |
58.14 | 75.47 | 57.55 | 46.22 | |
Average Common Equity |
42.18 | 36.32 | 43.32 | 32.79 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates